Module 3 / Lesson 9.4.2
Ability to Use Technology to Make New Medicine
Modern medicine is shifting from bespoke, long-lead drug development toward platform-based approaches. In these models, once a delivery system is established, new targets can be “plugged in” and developed much more quickly. A clear exemplar is the messenger RNA (mRNA) vaccine platform.
Learning: Watch the video to understand the concept of a "platform-based approach" in medicine. Specifically, identify how the mRNA platform differs from traditional vaccine development in terms of speed and adaptability.
Reflection: As you watch the video, constraints do you believe poses the biggest hurdle to quickly deploying a new platform vaccine during a future pandemic, and why?
Watch the video below to understand how mRNA technique was used to develop COVID vaccine.
Implications & Broader Applications
- Platform technologies mean that emerging pathogens can potentially be addressed more rapidly, reducing the time from pathogen discovery to vaccine deployment.
- The same platform is now being explored for other uses: cancer vaccines, rare genetic disorders, and other infectious diseases.
- Students should reflect on system-level constraints beyond technology: manufacturing scale-up, regulatory pathways, distribution logistics, cold chain, and public acceptance.
Your progress stays in this browser.